Intraperitoneal perfusion of endostatin improves the effectiveness and prolongs the prognosis of patients with gastric cancer
Overall, intraperitoneal RH-endostatin improved treatment efficacy and prolonged prognosis in patients with GC and malignant ascites. This approach may benefit further clinical applications for treating GC.
Authors
- Honggen Liu
- Cheng Zhao (ORCID: https://orcid.org/0000-0002-4308-1037)
- Yong Liu (ORCID: https://orcid.org/0000-0003-1254-1026)
Institutions
- Tianjin University of Traditional Chinese Medicine (CN)
- Tianjin Medical University Cancer Institute and Hospital (CN)
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Oncology
- Published
- 2025-03-24
- DOI
- https://doi.org/10.4251/wjgo.v17.i4.103131
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00